Universal Health Services (NYSE:UHS) experienced a sharp decline in after-hours trading on Monday, with shares falling approximately 5% to $151.21. The drop came after the hospital operator revised its 2026 profit outlook downward, citing ongoing uncertainty surrounding Medicaid reimbursement. This erased nearly all gains made since July 17, when the stock had been trading near $159.31.
Guidance Revision Details
The company now expects adjusted earnings per share in the range of $22.28 to $23.65, down from its previous guidance of $22.64 to $24.52. Revenue projections were adjusted to between $18.50 billion and $18.76 billion, with the midpoint increasing by a modest 0.2%. However, the midpoint for adjusted EBITDA was lowered by 1.9%, and adjusted EPS midpoint declined by 2.6%.
Q2 2026 Performance
Universal Health Services reported second-quarter results that slightly exceeded Wall Street expectations. Adjusted earnings per share came in at $5.98, edging past the LSEG consensus estimate of $5.96. Revenue reached $4.638 billion, surpassing the $4.58 billion projection. Net income attributable to UHS rose 1.5% to $358.4 million, while diluted earnings per share increased 10.1% to $5.98. However, diluted weighted shares outstanding fell 7.8% to 59.9 million, highlighting the significant impact of share repurchases on EPS growth.
Share Buyback Impact
Calculations indicate that nearly 85% of the quarterly EPS increase was attributable to the lower number of diluted shares. On a constant-share basis, EPS would have been approximately $5.52, only about eight cents higher than the prior year. During the quarter, UHS acquired 1.89 million shares for $320.3 million, paying an average price of roughly $169 per share. As of late Monday, the stock was trading nearly 11% below that average. At June 30, $977.6 million remained available under the company's repurchase authorization.
Operational Highlights
Demand for services remained robust. Adjusted admissions for acute care climbed 2.9%, while behavioral admissions edged up 0.5%. Revenue per adjusted admission in behavioral services rose 7.1%. Adjusted EBITDA increased by 5.4% to $677.9 million, though its margin slipped to 14.6% from 15.0% in the prior year period. Revenue advanced 8.3% to $4.64 billion.
Florida Medicaid and Other Factors
The results included a net pretax gain of $72 million, reflecting a $100 million advantage from Florida Medicaid that offset a $28 million increase in liability reserves. UHS has indicated it does not expect any additional benefit from Florida beyond September 2025. The company's outlook remains cautious due to uncertainty about future Medicaid reimbursement levels.
Market Context
Universal Health Services continues to trade at a significant valuation discount compared to its peers. As of Monday's close, UHS was valued at 6.7 times trailing earnings, while HCA Healthcare (NYSE:HCA) traded at 13.4 times and Tenet Healthcare (NYSE:THC) at 12.7 times. The stock had gained 3.0% over the past week and advanced another 2.3% on Monday before the after-hours decline.
Cash Flow and Capital Expenditure
Operating cash flow for the first half of the year declined 7% to $845 million. Capital expenditure guidance remains unchanged at $950 million to $1.1 billion. The company's cash conversion has weakened, which may raise concerns about its ability to sustain the pace of share repurchases.
Upcoming Investor Meeting
Management is scheduled to meet with investors at 9 a.m. EDT Tuesday. Discussion topics are expected to include Florida reimbursement, margins, and the pace of share buybacks. UHS also projects that its acquisition of Talkspace (NASDAQ:TALK) will be finalized in the third quarter, though this introduces additional financing and integration uncertainties.
Risks and Outlook
Key risks include potential delays in securing CMS approval for supplemental Medicaid payments, the possibility of further increases in liability reserves, and significant capital expenditures that restrict operational flexibility. While volume increased during the quarter, the updated outlook suggests that a smaller share of that revenue may flow through to earnings going forward.
